Julia Reznick is the VP of Global Portfolio and Pipeline for Teva Global Specialty Medicine, a division of the Top Ten global pharmaceutical company. In this webinar, Julia explains why she describes portfolio management as the “spinal cord” of an organization. She describes the role SmartOrg® played in Teva’s portfolio management success.
In 2010, Teva faced the imminent expiration of patent protection on its flagship product. They looked to portfolio management as the way to focus their development efforts and create sustainable growth to replace that product.
Soon after, Teva acquired Cephalon. This required a major realignment and harmonization of development and product portfolios.
Julia tells how Teva successfully made both of these transitions. She explains how Teva used portfolio management to coordinate the planning and execution by all of its parts to achieve the organization’s strategic goals. She also describes the role SmartOrg® played in Teva’s portfolio management success.
David Matheson, President and CEO of SmartOrg, introduces Julia with some remarks on the portfolio management journey. During and after Julia’s prepared presentation, she responds to audience questions. There are also three audience polls about the issues of strategic portfolio management.
To submit your own questions to Julia, to find out more about SmartOrg, or to keep informed of upcoming webinars, please email Stuart Creque at email@example.com.
Original Date and Time
Tuesday, April 25, 2017
09:00 Pacific Standard Time / 12:00 Noon Eastern Standard Time